Study future

RSV (Respiratory Syncytial Virus)

ANIMA Research is conducting research into a study vaccine for Respiratory Syncytial Virus (RSV). RSV is a contagious virus that can affect anyone and can lead to serious respiratory diseases, especially in older adults.

What is RSV?
RSV (Respiratory Syncytial Virus) causes respiratory infections. In mild cases, the symptoms resemble those of a common cold, but RSV can be more serious in older people.

Common symptoms in older adults include:

• Coughing, runny nose and sore throat
• Shortness of breath or wheezing
• Fatigue and general feeling of sickness
• Fever and chills

Please note: RSV is different from influenza. Even if you have been vaccinated against influenza, you can still get an RSV infection.

Purpose of the study
The purpose of this study is to test an RSV study vaccine in adults aged 60 years and older. The study will investigate:

• whether the vaccine is effective in preventing RSV infections
• how safe and well tolerated the vaccine is
• what the impact is on health and daily functioning

Participants receive optimal medical supervision and support from the ANIMA research center.

DOWNLOADS

• What is RSV?
• Brochure study